Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma

Cancer

Volumn 117, Issue 13, 2011, Pages 2910-2916

  Chen, Yuan Yuan ^a   Zhao, Chong ^a   Wang, Jin ^a   Ma, Hong Lian ^a   Lai, Shu Zheng ^a   Liu, Yuan ^b   Han, Fei ^a   Lu, Li Xia ^a   Bao, Yong ^a   Chen, Ming ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

intensity modulated radiation therapy; nasopharyngeal carcinoma; radiation damage; temporomandibular joint; trismus

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL TRIAL; DISEASE SEVERITY; DOSIMETRY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION HAZARD; RADIOLOGICAL PARAMETERS; TRISMUS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TEMPOROMANDIBULAR JOINT; TRISMUS;

EID: 79959598017     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25773     Document Type: Article

References (20)

1. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China [serial online]. BMC Cancer. 2006; 6: 178.
2. Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY,. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 2005; 62: 672-679. (Pubitemid 40779753)
3. Qin DX, Hu YH, Yan JH, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988; 61: 1117-1124.
4. Chen M, Zeng X, Zhao C, et al. Radiation-induced temporomandibular joint lesion in patients with nasopharyngeal carcinoma. Chin J Cancer. 2001; 20: 651-653.
5. Dijkstra PU, Kalk WW, Roodenburg JL,. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004; 40: 879-889. (Pubitemid 39369559)
6. Goldstein M, Maxymiw WG, Cummings BJ, Wood RE,. The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 365-373.
7. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ,. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000; 48: 329-337.
8. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007; 25: 4873-4879. (Pubitemid 350220416)
9. Chau RM, Teo PM, Kam MK, Leung SF, Cheung KY, Chan AT,. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim. 2007; 32: 263-270. (Pubitemid 350016880)
10. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2000; 48: 711-722.
11. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002; 53: 12-22. (Pubitemid 34465802)
12. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004; 101: 1584-1593. (Pubitemid 39318905)
13. Kam MKM, Chau RMC, Suen J, Choi PHK, Teo PML,. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003; 56: 145-157. (Pubitemid 36403686)
14. Hsiung CY, Huang EY, Ting HM, Huang HY,. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol. 2008; 81: 809-814.
15. Zhao C, Han F, Lu LX, et al. Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma [in Chinese]. Ai Zheng. 2004; 23 (11 suppl): 1532-1537.
16. Sakai S, Kubo T, Mori N, et al. A study of the late effects of radiotherapy and operation on patients with maxillary cancer. A survey more than 10 years after initial treatment. Cancer. 1988; 62: 2114-2117. (Pubitemid 18261847)
17. LENT SOMA tables. Radiother Oncol. 1995; 35: 17-60.
18. Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005; 74: 251-258. (Pubitemid 40349134)
19. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ,. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006; 64: 57-62. (Pubitemid 41831209)
20. Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY,. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope. 2005; 115: 1458-1460.